A new candidate oncogenic lncRNA derived from pseudogene WFDC21P promotes tumor progression in gastric cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A new candidate oncogenic lncRNA derived from pseudogene WFDC21P promotes tumor progression in gastric cancer
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 12, Issue 10, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-10-04
DOI
10.1038/s41419-021-04200-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Methyladenosine Modification in RNAs: Classification and Roles in Gastrointestinal Cancers
- (2021) Qinghai Li et al. Frontiers in Oncology
- TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2
- (2020) You Shuai et al. Molecular Cancer
- Regulation of the small GTPase Ran by miR-802 modulates proliferation and metastasis in colorectal cancer cells
- (2020) Xin Wang et al. BRITISH JOURNAL OF CANCER
- Long noncoding RNA AGPG regulates PFKFB3-mediated tumor glycolytic reprogramming
- (2020) Jia Liu et al. Nature Communications
- Ran GTPase: A Key Player in Tumor Progression and Metastasis
- (2020) Zied Boudhraa et al. Frontiers in Cell and Developmental Biology
- The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation
- (2019) Xi Jin et al. Science Advances
- National trend of gastric cancer mortality in China (2003–2015): a population-based study
- (2019) Kun Gao et al. Cancer Communications
- LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer
- (2019) Yun Wang et al. Molecular Cancer
- Identification of Key Genes and Signaling Pathways Associated with the Progression of Gastric Cancer
- (2019) Chaoran Yu et al. PATHOLOGY & ONCOLOGY RESEARCH
- LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer
- (2018) Jing Zhao et al. ONCOGENE
- Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis
- (2018) Ting Li et al. World Journal of Surgical Oncology
- Long noncoding RNA MALAT1 suppresses breast cancer metastasis
- (2018) Jongchan Kim et al. NATURE GENETICS
- JAK2-binding long noncoding RNA promotes breast cancer brain metastasis
- (2017) Shouyu Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- Long Noncoding RNA C21orF96 Promotes the Migration, Invasion and Lymph Node Metastasis in Gastric Cancer
- (2016) Ziguo Yang et al. Anti-Cancer Agents in Medicinal Chemistry
- Cancer Incidence and Mortality Survey in Wuwei, Gansu Province, Northwestern China from 2003 to 2012: A Retrospective Population-based Study
- (2016) Ge-Yu Liang et al. CHINESE MEDICAL JOURNAL
- Roles of long noncoding RNAs in gastric cancer and their clinical applications
- (2016) Weiliang Sun et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Advanced gastric cancer: Current treatment landscape and future perspectives
- (2016) Antonia Digklia WORLD JOURNAL OF GASTROENTEROLOGY
- Correlation between FOXP3 expression and gastric cancer
- (2016) Guoxiao Guo et al. Oncology Letters
- LncRNA GClnc1 Promotes Gastric Carcinogenesis and May Act as a Modular Scaffold of WDR5 and KAT2A Complexes to Specify the Histone Modification Pattern
- (2016) T.-T. Sun et al. Cancer Discovery
- Long noncoding RNA OR3A4 promotes metastasis and tumorigenicity in gastric cancer
- (2016) Xiaobo Guo et al. Oncotarget
- Ran GTPase protein promotes metastasis and invasion in pancreatic cancer by deregulating the expression of AR and CXCR4
- (2014) Lin Deng et al. CANCER BIOLOGY & THERAPY
- Ran GTPase Induces EMT and Enhances Invasion in Non-Small Cell Lung Cancer Cells Through Activation of PI3K-AKT Pathway
- (2014) Jinfeng Ning et al. ONCOLOGY RESEARCH
- Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways
- (2011) H.-F. Yuen et al. CLINICAL CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started